Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc News Story

$5.95 0.0  0.0%

Last Trade - 06/11/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.9m
Position in Universe th / 6715

BRIEF-Dimension Therapeutics says co's board determined proposal from Ultragenyx Pharmaceutical could reasonably be expected to lead to "superior proposal"

Tue 19th September, 2017 1:05pm
Sept 19 (Reuters) - Dimension Therapeutics Inc  DMTX.O  
    * Dimension Therapeutics - Dimension board determines 
proposal from Ultragenyx Pharmaceutical could reasonably be 
expected to lead to "superior proposal" 
    * Dimension Therapeutics -co's board has not determined 
ultragenyx's proposal in fact constitutes superior proposal 
under existing deal with Regenxbio 
    * Dimension Therapeutics Inc - board has not changed its 
recommendation in support of merger with Regenxbio 
 
Source text for Eikon:  ID:nGNXOEILNa  
Further company coverage:  DMTX.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.